About Chris McDonald
Form D filings for Nucleus Radiopharma in 2024 list Chris McDonald as director.
Chris McDonald first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Chris McDonald in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Chris McDonald works with at each company, as listed on that company's latest Form D.
Nucleus Radiopharma, Inc. · Form D, Apr 11, 2024
CC
Charles Conroy
Chief Executive Officer and director
JB
Justin Butler
Director
MN
Manu Nair
Director
TR
Tyrell Rivers
Director
NS
Norman Sharpless
Director
MR
Michael Rossi
Director
MW
Mary Kate Wold
Director